cilazapril, anhydrous has been researched along with Diabetic Glomerulosclerosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (66.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, M; Berla, M; Kedar, Y; Levi, Z; Rachmani, R; Ravid, M; Slavachevsky, I | 1 |
| Imamura, M; Kobayashi, D; Mori, M; Nagai, T | 1 |
| Bowen, KM; Lowe, J; Pater, G; Phillipou, G; Phillips, PJ; Wischusen, J; Yue, DK | 1 |
| Brocco, E; Carraro, A; Cernigoi, AM; Fioretto, P; Fresu, P; Frigato, F; Maioli, M; Muollo, B; Nosadini, R; Tonolo, G; Velussi, M; Zolli, M | 1 |
| Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Wanibuchi, H; Yamanaka, S | 1 |
| Fujii, S; Imanishi, M; Kimura, G; Konishi, Y; Okumura, M; Tanaka, S; Yoshioka, K | 1 |
| Half-Onn, E; Levi, Z; Rachmani, R; Ravid, M; Slavachevsky, I | 1 |
| Ebihara, I; Koide, H; Nakamura, T; Shimada, N | 1 |
| Yee, J | 1 |
| Endo, M; Fujita, T; Hidaka, M; Ohi, H; Ohsawa, I; Satomura, A | 1 |
| Delles, C; Hilgers, KF; Schmieder, RE; Veelken, R | 1 |
| Ben-Ishay, D; Bursztyn, M; Fidel, J; Kobrin, I | 1 |
7 trial(s) available for cilazapril, anhydrous and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study.
Topics: Aged; Albuminuria; Blood Pressure; Cilazapril; Creatinine; Diabetic Nephropathies; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Prospective Studies; Spironolactone | 2004 |
Diabetic microalbuminuria and cilazapril.
Topics: Adolescent; Adult; Aged; Albuminuria; Cilazapril; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Male; Middle Aged | 1993 |
Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cilazapril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Glomerular Filtration Rate; Humans; Hypertension; Middle Aged; Proteinuria | 1996 |
Mechanism of decreased albuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Diabetic Nephropathies; Diet, Sodium-Restricted; Female; Humans; Kidney Glomerulus; Male; Middle Aged; Natriuresis | 1997 |
Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cilazapril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Doxazosin; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney Function Tests; Male; Middle Aged | 1998 |
Angiotensin-converting enzyme inhibitors improve nephrosis more quickly than calcium antagonists in diabetic patients.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cilazapril; Diabetic Nephropathies; Female; Humans; Hypertension, Renal; Male; Middle Aged; Nephrosis; Prospective Studies; Proteinuria; Renal Circulation | 2000 |
Outcome survey in unselected hypertensive patients with type 2 diabetes mellitus: effects of ACE inhibition.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Edema; Female; Follow-Up Studies; Humans; Hypertension, Renal; Male; Middle Aged; Patient Selection; Prospective Studies; Proteinuria; Treatment Outcome | 2001 |
5 other study(ies) available for cilazapril, anhydrous and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
A case report of a diabetic nephropathy patient with cirrhotic ascites treated by peritoneal dialysis.
Topics: Amino Acids, Branched-Chain; Angiotensin-Converting Enzyme Inhibitors; Ascites; Blood Urea Nitrogen; Cilazapril; Creatinine; Diabetic Nephropathies; Edema; Humans; Liver Cirrhosis; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 2007 |
Angiotensin blockade improves cardiac and renal complications of type II diabetic rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Glucose Tolerance Test; Imidazoles; Insulin; Male; Proteinuria; Pyridines; Rats; Rats, Inbred Strains | 1997 |
Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cilazapril; Collagenases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Hypertension, Renovascular; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Middle Aged; Severity of Illness Index; Time Factors; Tissue Inhibitor of Metalloproteinase-1 | 1998 |
Plasma matrix metalloproteinase-9 and diabetic microalbuminuria: tip of the iceberg?
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cilazapril; Collagenases; Diabetic Nephropathies; Humans; Hypertension, Renovascular; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Tissue Inhibitor of Metalloproteinase-1 | 1998 |
Improved kidney function with cilazapril in hypertensive type II diabetics with chronic renal failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Rate; Humans; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Pyridazines | 1991 |